Spread of CTX-M-15 extended spectrum β-lactamases encoding genes among enterobacteriaceae in the middle eastern region

International Arabic Journal of Antimicrobial Agents

Volumn 1, Issue 1, 2011, Pages

  Baroud, Maysa ^a   Araj, George F ^b   Matar, Ghassan M ^a,b  

^a Immunology and Microbiology   (Lebanon)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Antimicrobial resistance; CTX M 15; Enterobacteria ceae; ESBL; Middle East

Indexed keywords

ENTEROBACTERIACEAE;

EID: 84871146794     PISSN: None     EISSN: 21749094     Source Type: Journal    
DOI: 10.3823/703     Document Type: Article

References (77)

1. Kliebe C, Nies BA, Meyer JF, Tolxdorf-Neutzling RM, Wiedemann B: Evolution of plasmid-coded resistance to broad-spectrum cephalosporins. Antimicrob Agents Chemother 1985, 28(2): 302-307
2. Bradford PA: Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat. Clin Microbiol Rev 2001, 14(4): 933-951
3. Livermore DM, Woodford N: The β-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter. Trends Microbiol 2006, 14(9): 412-420
4. Bauemfeind A, Grimm H, Schweighart S: A New Plasmidic Cefotaximase in a Clinical Isolate of Escherichia coli. Infection 1990, 18(5): 294-298
5. Paterson DL, Bonomo RA: Extended-Spectrum β-Lactamases: a Clinical Update. Clin Microbiol Rev 2005, 18(4): 657-686
6. Livermore D, Cantón R, Gniadkowski M, Nordmann P, Rossolini GM, Arlet G, Ayala J, Coque TM, Kern-Zdanowicz I, Luzzaro F, Poirel L, Woodford N: CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother 2006, 59(2): 165-174
7. Cantón R, Novais A, Valverde A, Machado E, Peixe L, Baquero F, Coque TM: Prevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe. Eur J Clin Microbiol Infect Dis 2008, Suppl. 1: 144-153
8. Pitout JDD, Laupland KB: Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008, 8(3): 159-166
9. Cantón R, Coque TM: The CTX-M β-lactamase pandemic. Curr Opin Microbiol 2006, 9(5): 466-475
10. Villegas MV, Kattan JN, Quinteros MG, Casellas JM: Prevalence of extended-spectrum β-lactamases in South America. Clin Microbiol Infect 2008, 14(Suppl. s1): 154-158
11. Poirel L, Lartigue MF, Decousser JW, Nordmann P: ISEcp1B-Mediated Transposition of blaCTX-M in Escherichia coli. Antimicrob Agents Chemother 2005, 49(1): 447-550
12. Baroud M, Araj GF, Wakim R, Kanj S, Kanafani Z, Khairallah M, Sabra A, Shehab M, Dbaibo G, Matar GM: Underlying Mechanisms of Carbapenem Resistance in ESBL-Producing Enterobacteriaceae at a Tertiary Care Center in Lebanon. 51st Intersci Conf Antimicrob Agents Chemother. abstr. C1-1108
13. Gröbner S, Linke D, Schutz W, Fladerer C, Madlung J, Autenrieth IB, Witte W, Pfeifer Y: Emergence of carbapenem-non-susceptible extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tübingen, Germany. J Med Microbiol 2009, 58(Pt 7): 912-922
14. Karim A, Poirel L, Nagarajan S, Nordmann P: Plasmid-mediated extended-spectrum β-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1. FEMS Microbiol Lett 2001, 201(2): 237-241
15. Nordmann P, Poirel L: Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae. J Antimicrob Chemother 2005, 56(3): 463-469
16. Jacoby GA, Walsh KE, Mills DM, Walker VJ, Oh H, Robicsek A, Hooper DC: qnrB, Another Plasmid-Mediated Gene for Quinolone Resistance. Antimicrob Agents Chemother 2006, 50(4): 1178-1182
17. Machado E, Coque TM, Cantón R, Baquero F, Sousa JC, Peixe L: Dissemination in Portugal of CTX-M-15-, OXA-1-, and TEM-1-Producing Enterobacteriaceae Strains Containing the aac(6')-Ib-cr Gene, Which Encodes an Aminoglycoside- and Fluoroquinolone-Modifying Enzyme. Antimicrob Agents Chemother 2006, 50(9): 3220-3221
18. Karisik E, Ellington MJ, Pike R, Ward ME, Fagan EJ, Livermore DM, Woodford N: Molecular characterization of plasmids from CTX-M-15-producing Escherichia coli strains responsible for outbreaks in the United Kingdom. Clin Microbiol Infect 2005, 11(Suppl. 2): P471
19. Harajly M, Khairallah MT, Corkill JE, Araj GF, Matar GM: Frequency of conjugative transfer of plasmid-encoded ISEcp1 - blaCTX-M-15 and aac(6')-lb-cr genes in Enterobacteriaceae at a tertiary care center in Lebanon - role of transferases. Ann Clin Microbiol Antimicrob 2010, 9(19)
20. Peiranoa G, Pitout JDD: Molecular epidemiology of Escherichia coli producing CTX-M β-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents 2010, 35(4): 316- 321
21. Ensor VM, Shahid M, Evans JT, Hawkey PM: Occurrence, prevalence and genetic environment of CTX-M β-lactamases in Enterobacteriaceae from Indian hospitals. J Antimicrob Chemother 2006, 58(6): 1260-1263
22. Varsha G, Datta P: Extended-spectrum β-lactamases (ESBL) in community isolates from North India: frequency and predisposing factors. Int J Infect Dis 2007, 11(1): 88-89
23. Lewis JS, Herrera M, Wickes B, Patterson JE, Jorgensen JH: First Report of the Emergence of CTX-M-Type Extended-Spectrum ß-Lactamases (ESBLs) as the Predominant ESBL Isolated in a U.S. Health Care System. Antimicrob Agents Chemother 2001, 51(11): 4015-4021
24. Mulvey MR, Bryce E, Boyd D, Ofner-Agostini M, Christianson S, Simor AE, Paton S, Canadian Hospital Epidemiology Committee, Canadian Nosocomial Infection Surveillance Program, Health Canada: Ambler Class A Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella spp. in Canadian Hospitals. Antimicrob Agents Chemother 2004, 48(4): 1204-1214
25. Hawkey PM: Prevalence and clonality of extended-spectrum B-lactamases in Asia. Clin Microbiol Infect 2008, 14(Suppl. s1): 159-165
26. Zong Z, Partridge SR, Thomas L, Iredell JR: Dominance of blaCTX-M within an Australian Extended-Spectrum β-Lactamase Gene Pool. Antimicrob Agents Chemother 2008, 52(11): 4198-4202
27. Mamlouk K, Boutiba-Ben Boubaker I, Gautier V, Vimont S, Picard B, Ben Redjeb S, Arlet G: Emergence and Outbreaks of CTX-M ß-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Strains in a Tunisian Hospital. J Clin Microbiol 2006, 44(11): 4049-4056
28. Moubareck C, Daoud Z, Hakimé NI, Hamze M, Mangeney N, Matta H, Mokhbat JE, Rohban R, Sarkis DK, Doucet-Populaire F: Countrywide Spread of Community- and Hospital-Acquired Extended-Spectrum β-Lactamase (CTX-M-15)-Producing Enterobacteriaceae in Lebanon. J Clin Microbiol 2005, 43(7): 3309-3313
29. Al-Agamy MHM, Ashour MSE, Wiegand I: First description of CTX-M β-lactamase-producing clinical Escherichia coli isolates from Egypt. Int J Antimicrob Agents 2006, 27(6): 545-548
30. Ensor VM, Jamal W, Rotimic VO, Evans JT, Hawkey PM: Predominance of CTX-M-15 extended spectrum β-lactamases in diverse Escherichia coli and Klebsiella pneumoniae from hospital and community patients in Kuwait. Int J Antimicrob Agents 2009, 33(5): 487-489
31. Sonnevend A, Al Dhaheri K, Mag T, Herpay M, Kolodziejek J, Nowotny N, Usmani A, Sheikh FA, Pál A: CTX-M-15-producing multidrug-resistant enteroaggregative Escherichia coli in the United Arab Emirates. Clin Microbiol Infect 2006, 12(6): 582-585
32. El Kholy A, Baseem H, Hall GS, Procop GW, Longworth DL: Antimicrobial resistance in Cairo, Egypt 1999-2000: a survey of fve hospitals. J Antimicrob Chemother 2003, 51(3): 625-630
33. Borg MA, van de Sande-Bruinsma N, Scicluna E, de Kraker M, Tiemersma E, Monen J, Grundmann H, ARMed Project Members and Collaborators: Antimicrobial resistance in invasive strains of Escherichia coli from southern and eastern Mediterranean laboratories. Clin Microbiol Infect 2008, 14(8): 789-796
34. Fam N, Lefon-Guibout V, Fouad S, Aboul-Fadl L, Marcon E, Desouky D, El-Defrawy I, Abou-Aitta A, Klena J, Nicolas-Chanoine MH: CTX-M-15-Producing Escherichia coli Clinical Isolates in Cairo (Egypt), Including Isolates of Clonal Complex ST10 and Clones ST131, ST73, and ST405 in Both Community and Hospital Settings. Microb Drug Resist 2011, 17(1): 67-73
35. Feizabadi M, Etemadi G, Yadegarinia D, Rahmati M, Shabanpoor S, Bokaei: Antibiotic-resistance patterns and frequency of extended-spectrum β-lactamase-producing isolates of Klebsiella pneumoniae in Tehran. Med Sci Monit 2006, 12(1): BR362-365
36. Mehrgan H, Rahbar M: Prevalence of extended-spectrum β-lactamase-producing Escherichia coli in a tertiary care hospital in Tehran, Iran. Int J Antimicrob Agents 2008, 31(2): 147-151
37. Ramazanzadeh R, Chitsaz M, Bahmani N: Prevalence and Antimicrobial Susceptibility of Extended-Spectrum Beta-Lactamase-Producing Bacteria in Intensive Care Units of Sanandaj General Hospitals (Kurdistan, Iran). Chemotherapy 2009, 55(4): 287-292
38. Feizabadi MM, Delfani S, Raji N, Majnooni A, Aligholi M, Shahcheraghi F, Parvin M, Yadegarinia D: Distribution of bla(TEM), bla(SHV), bla(CTX-M) genes among clinical isolates of Klebsiella pneumoniae at Labbafnejad Hospital, Tehran, Iran. Microb Drug Resist 2010, 16(1): 49-53
39. Feizabadi MM, Mahamadi-Yeganeh S, Mirsalehian A, Mirafshar SM, Mahboobi M, Nili F, Yadegarinia D: Genetic characterization of ESBL-producing strains of Klebsiella pneumoniae from Tehran hospitals. J Infect Dev Ctries 2010, 4(10): 609-615.
40. Hamidian M, Tajbakhsh M, Walther-Rasmussen J, Zali MR: Emergence of extended-spectrum β-lactamases in clinical isolates of Salmonella enterica in Tehran, Iran. Jpn J Infect Dis 2009, 62(5): 368-371
41. Ranjbar R, Giammanco GM, Aleo A, Plano MR, Naghoni A, Owlia P, Mammina C: Characterization of the frst extended-spectrum beta-lactamase-producing nontyphoidal Salmonella strains isolated in Tehran, Iran. Foodborne Pathog Dis 2010, 7(1): 91-95
42. Al-Charrakh AH, Yousif SY, Al-Janabi H: Occurrence and detection of extended-spectrumβ-lactamases in Klebsiella isolates in Hilla, Iraq. African Journal of of Biotechnology 2011, 10(4): 657-665
43. Poirel L, Fortineau N, Nordmann P: International Transfer of NDM-1-Producing Klebsiella pneumoniae from Iraq to France. Antimicrob Agents Chemother 2011, 55(4): 1821-1822
44. Pfeifer Y, Matten J, Rabsch W: Salmonella enterica Serovar Typhi with CTX-M β-Lactamase, Germany. Emerg Infect Dis 2009, 15(9): 1533-1535
45. Nicolas-Chanoine MH, Blanco J, Lefon-Guibout V, Demarty R, Alonso MP, Caniça MM, Park YJ, Lavigne JP, Pitout J, Johnson JR: Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 2008, 61(2): 273-281
46. Coque TM, Novais Â, Carattoli A, Poirel L, Pitout J, Peixe L, Cantón R, Nordmann P: Dissemination of Clonally Related Escherichia coli Strains Expressing Extended-Spectrum β-Lactamase CTX-M-15. Emerg Infect Dis 2008, 14(2): 195-200
47. Rotimi VO, Jamal W, Pal T, Sovenned A, Albert MJ: Emergence of CTX-M-15 type extended-spectrum β-lactamase-producing Salmonella spp. in Kuwait and the United Arab Emirates. J Med Microbiol 2008, 57(7): 881-886
48. Al Sweih N, Salama MF, Jamal W, Al Hashem G, Rotimi VO: An outbreak of CTX-M-15-producing Klebsiella pneumoniae isolates in an intensive care unit of a teaching hospital in Kuwait. Indian J Med Microbiol 2011, 29(2): 130-135
49. Dashti AA, Jadaon MM, Gomaa HH, Noronha B, Udo EE: Transmission of a Klebsiella pneumoniae clone harbouring genes for CTX-M-15-like and SHV-112 enzymes in a neonatal intensive care unit of a Kuwaiti hospital. J Med Microbiol 2010, 59(6): 687-692
50. Al Hashem G, Al Sweih N, Jamal W, Rotimi VO: Sequence Analysis of blaCTX-M Genes Carried by Clinically Signifcant Escherichia coli Isolates in Kuwait Hospitals. Med Princ Pract 2010, 20(3): 213-219
51. Kanj SS, Corkill JE, Kanafani ZA, Araj GF, Hart CA, Jaafar R, Matar GM: Molecular characterisation of extended spectrum β-lactamase-producing Escherichia coli and Klebsiella spp. isolates at a tertiary-care centre in Lebanon. Eur J Clin Microbiol Infect Dis 2008, 14(5): 501-504
52. Matar GM, Jaafar R, Sabra A, Hart CA, Corkill JE, Dbaibo GS, Araj GF: First detection and sequence analysis of the bla-CTX-M-15 gene in Lebanese isolates of extended-spectrum-β-lactamase-producing Shigella sonnei. Ann Trop Med Parasitol 2007, 101(6): 511-517
53. Moubareck C, Doucet-Populaire F, Hamze M, Daoud Z, Weill FX: First Extended-Spectrum-β-Lactamase (CTX-M-15)-Producing Salmonella enterica Serotype Typhimurium Isolate Identifed in Lebanon. Antimicrob Agents Chemother 2005, 49(2): 864-865
54. Matar GM, Kattar MM, Khairallah MT, Abi-Rached R, Mokhbat J: Detection of plasmid-encoded bla-CTX-M-15 and bla-TEM-1 genes in a Lebanese Salmonella isolate that produces extended-spectrum β-lactamase. Ann Trop Med Parasitol 2008, 102(7): 651-653
55. Matar GM, Khairallah MT, Dandache I, Sabra A, Mokhbat J: Further evidence of plasmid-encoded bla-CTX-M-15 and bla-TEM-1 genes in Lebanese isolates of Salmonella enterica serovar Typhimurium that produce extended-spectrum β-lactamase. Ann Trop Med Parasitol 2010, 104(1): 91-94
56. Rafay AM, Al-Muharrmi Z, Toki R: Prevalence of extended-spectrum beta-lactamases-producing isolates over a 1-year period at a University Hospital in Oman. Saudi Med J 2007, 28(1): 22-27
57. Al Muharrmi Z, Rafay AM, Balkhair A, Al-Tamemi S, Al Mawali A, Al Sadiri H: Extended-spectrum β-lactamase (ESBL) in Omani Children: Study of prevalence, risk factors and clinical outcomes at Sultan Qaboos University Hospital, Sultanate of Oman. Sultan Qaboos Univ Med J 2008, 8(2): 171-177
58. Al-Lawati AM, Crouch ND, Elhag KM: Antibiotic Consumption and Development of Resistance Among Gram-Negative Bacilli in Intensive Care Units In Oman. Ann Saudi Med 2000, 20(Nos 3-4): 324-327
59. Al-Yaqoubi M, Elhag K: Susceptibilities of Common Bacterial Isolates from Oman to Old and New Antibiotics. Oman Med J 2008, 23(3)
60. Poirel L, Al Maskari Z, Al Rashdi F, Bernabeu S, Nordmann P: NDM-1-producing Klebsiella pneumoniae isolated in the Sultanate of Oman. The J Antimicrob Chemother 2010, 66(2): 304-306
61. Al-Agamy MHM, Shibl AM, Tawfk AF: Prevalence and molecular characterization of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in Riyadh, Saudi Arabia. Ann Saudi Med 2009, 29(4): 253-257
62. Bindayna K, Khanfar HS, Senok AC, Botta GA: Predominance of CTX-M genotype among extended spectrum β-lactamase isolates in a tertiary hospital in Saudi Arabia. Saudi Med J 2010, 30(8): 859-863
63. Tawfk AF, Alswailem AM, Shibl AM, Al-Agamy MH: Prevalence and genetic characteristics of TEM, SHV, and CTX-M in clinical Klebsiella pneumoniae isolates from Saudi Arabia. Microb Drug Resist 2011, 17(3): 383-388
64. Lartigue MF, Poirel L, Héritier C, Tolün V, Nordmann P: First description of CTX-M-15-producing Klebsiella pneumoniae in Turkey. J Antimicrob Chemother 2003, 52(2): 315-316
65. Yildirim I, Ceyhan M, Gur D, Mugnaioli C, Rossolini G: First Detection of VIM-1 Type Metallo-β-Lactamase in a Multidrug-Resistant Klebsiella pneumoniae Clinical Isolate from Turkey also Producing the CTX-M-15 Extended-Spectrum β-Lactamase. J Chemother 2007, 19(4): 467-468
66. Gonullu N, Aktas Z, Bal Kayacan C, Salcioglu M, Carattoli A, Yong DE, Walsh TR: Dissemination of CTX-M-15 β-Lactamase Genes Carried on Inc FI and FII Plasmids among Clinical Isolates of Escherichia coli in a University Hospital in Istanbul, Turkey. J Clin Microbiol 2008, 46(3): 1110-1112
67. Yumuk Z, Afacan G, Nicolas-Chanoine MH, Sotto A, Lavigne JP: Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15. J Antimicrob Chemother 2008; 62(2): 284-288
68. Celik AD, Yulugkural Z, Kuloglu F, Eroglu C, Torol S, Vahaboǧlu H, Akata F: CTX-M Type Extended Spectrum β-Lactamases in Escherichia coli Isolates From Community Acquired Upper Urinary Tract Infections at a University in the European Part of Turkey. J Microbiol Immunol Infect 2010, 43(2): 163-167
69. Azap O, Arslan H, Serefhanoǧlu K, Colakoǧlu S, Erdoǧan H, Timurkaynak F, Senger SS: Risk factors for extended-spectrum β-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections. Eur J Clin Microbiol Infect Dis 2010, 16(2): 147-151
70. Alfaresi MS, Elkoush AA, Alshehhi HM, Abdulsalam Al: Molecular Characterization and Epidemiology of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Isolates in the United Arab Emirates. Med Princ Pract 2011, 20(2): 177-180
71. Astal Z, Sharif FA, Abdallah SA, Fahd MI: Extended spectrum β-lactamases in Eschericia coli isolated from community-acquired urinary tract infections in the Gaza Strip, Palestine. Ann Saudi Med 2004, 24(1): 55-57
72. Mubarak Bindaynaa K, Senokc AC, Jamsheer AE: Prevalence of extended-spectrum β-lactamase-producing Enterobacteriaceae in Bahrain. J Infect Public Health 2009, 2(3): 129-135
73. Chmelnitsky I, Carmeli Y, Leavitt A, Schwaber MJ, Navon-Venezia S: CTX-M-2 and a New CTX-M-39 Enzyme Are the Major Extended-Spectrum β-Lactamases in Multiple Escherichia coli Clones Isolated in Tel Aviv, Israel. Antimicrob Agents Chemother 2005, 49(11): 4745-4750
74. Shehabi AA, Mahafzah A, Baadran I, Qadar FA, Dajani N: High incidence of Klebsiella pneumoniae clinical isolates to extended-spectrum B-lactam drugs in intensive care units. Diagn Microbiol Infect Dis 2000, 36(1):53-56
75. Khalaf NG, Eletreby MM, Hanson ND: Characterization of CTX-M ESBLs in Enterobacter cloacae, Escherichia coli and Klebsiella pneumoniae clinical isolates from Cairo, Egypt. BMC Infect Dis 2009, 9(84)
76. Paterson DL, Ko WC, Von Gottberg A, Casellas JM, Mulazimoglu L, Klugman KP, Bonomo RA, Rice LB, McCormack JG, Yu VL: Outcome of Cephalosporin Treatment for Serious Infections Due to Apparently Susceptible Organisms Producing Extended-Spectrum β-Lactamases: Implications for the Clinical Microbiology Laboratory. J Clin Microbiol 2001, 39(6): 2206-2212
77. Paterson DL, Yu VL: Extended spectrum β-lactamases: A Call for Improved Detection and Control. Clin Infect Dis 1999, 29(6):1419-1422